Sat.Aug 08, 2020 - Fri.Aug 14, 2020

article thumbnail

Seres finds the microbiome data it's been waiting for

Bio Pharma Dive

The biotech's value more than quadrupled after reporting pivotal data that, according to executives, "substantially exceeded" what's needed for approval.

332
332
article thumbnail

How pharma digital marketing can excel

World of DTC Marketing

Pharma digital marketing has been lagging behind key trends for a long while. Let’s face it, pharma organizations are not made for speed while digital marketing is all about “now” Digital marketing is also about experimentation and learning from successes as well as failures. An internal team of consultants, dedicated to digital, can add a lot of value to a company.

Marketing 302
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

In the News: July Regulatory and Development Updates

Camargo

Each month, Camargo’s “In the News” series will highlight important changes and advancements in the. The post In the News: July Regulatory and Development Updates appeared first on Camargo.

article thumbnail

American Gene Technologies Gets Go-Ahead to Test Possible HIV Cure

BioSpace

American Gene Technologies (AGT), based in Rockville, Maryland, received the go-ahead from the U.S. Food and Drug Administration (FDA) to begin a Phase I clinical trial of AGT103-T, a gene therapy, to eliminate HIV from infected individuals.

Gene 145
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

US puts Kodak loan on hold after stock scrutiny

Bio Pharma Dive

Lawmakers questioned the timing of stock options granted to Kodak executives a day before the planned $765 million loan was announced. An SEC investigation is reportedly underway.

314
314
article thumbnail

Pharma is hiring

World of DTC Marketing

IN BRIEF: Pharma companies have been posting jobs on LinkedIn almost every day. While most offices remain closed pharma is preparing for the launch of new products and has to have the infrastructure to ensure a successful launch. I keep in touch with all my clients via email newsletters and ask them to “stay in touch” It seems that this year, I’ve been seeing more people leave for other jobs within the industry or clients asking me to suggest people for open positions.

Branding 223

More Trending

article thumbnail

Using Machine Learning to ID Potential COVID-19 Treatments

BioSpace

Researchers at the University of California, Riverside leveraged machine learning to screen more than 10 million commercially available small molecules for interactions with SARS-CoV-2 viral proteins, and found hundreds of drugs that might offer treatments against COVID-19.

Protein 141
article thumbnail

FDA gives speedy approval to another Duchenne drug

Bio Pharma Dive

Viltepso, from Japanese drugmaker NS Pharma, is approved to treat the same subset of Duchenne patients as Sarepta's Vyondys 53.

Drugs 335
article thumbnail

Potential HIV cure Phase I trial gets FDA green light

Outsourcing Pharma

American Gene Technologies has received the agencyâs approval to launch the first human trial for its lead HIV program, starting in Baltimore and DC.

Trials 145
article thumbnail

Finding resilience after an HIV diagnosis

pharmaphorum

Author and journalist John-Manuel Andriote has spent much of his career writing about the impact of HIV/AIDS – a job that became much more personal when he himself was diagnosed in 2005. He tells pharmaphorum about the importance of resilience in coping with a serious illness. John first began writing about HIV/AIDS as a journalist in 1986. “I had two friends of mine in their 20s die from AIDS while I was in journalism school in 1985 – a time when AIDS was always in the news and there was a lot

Doctors 128
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Companies Press Ahead with COVID-19 Antibody Therapies

BioSpace

Although the world is eagerly awaiting news of an effective and safe vaccine against COVID-19, several companies are moving ahead testing therapeutic antibodies against the disease.

Antibody 140
article thumbnail

Moderna gets $1.5B from US for coronavirus vaccine supply

Bio Pharma Dive

The U.S. has already invested heavily in Moderna's vaccine, having previously committed $1 billion to fund clinical trials and manufacturing scale-up.

article thumbnail

Moderna makes commercial case for COVID-19 vaccine amid price pressure

BioPharma Reporter

Moderna Therapeutics reveals it is selling its COVID-19 vaccine for up to $37 a dose, well above the amount charged by some of its rivals.

article thumbnail

Bad behaviour: why understanding human behaviour can improve outcomes

pharmaphorum

Why did I do that? A common question I often ask myself after opening the biscuit packet for the third time in an hour. Only ten minutes before I had a mental argument with myself, which I thought I had won, promising not to eat another one until tomorrow. The process that goes on inside our heads, affecting the good and bad choices we make regarding our health every day, is the focus of health psychology and the growing interest around behavioural change.

Genetics 124
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Gut Enzymes Show Promise in Helping to Identify Potential Diseases

BioSpace

According to a study published in Nature Communications on August 11, enzymes that are used by bacteria to break down mucus in the gut can potentially be useful biomarkers for intestinal diseases.

Bacteria 137
article thumbnail

Russia, with scant study data, approves coronavirus vaccine

Bio Pharma Dive

The shot, developed by the state-backed Gamaleya Research Institute, hasn't yet been tested in the large, placebo-controlled tests scientists emphasize are needed to prove a vaccine is protective.

article thumbnail

Pfizer inks manufacturing deal with Gilead for COVID-19 med remdesivir

Pharma Times

Pfizer becomes one of multiple external manufacturing organisations supporting scale-up of treatment

article thumbnail

Digital depression therapy offers hope during COVID-19 pandemic

pharmaphorum

A new digital therapy is aiming to tackle depression during the COVID-19 pandemic, using a brain stimulation headset and therapy app that claims to have similar beneficial effects to drugs but with fewer side-effects. Flow is the first drug-free at-home treatment of its type to be approved in the EU and UK. While using the Flow headset, patients engaged with a therapy app program, which offers personalised behavioural therapy in areas proven to reduce symptoms of depression, including nutrition,

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

New RDIF Website Details Russia’s COVID-19 Vaccine as Global Phase III Trials Begin

BioSpace

Phase III clinical trials for Russia’s Sputnik V vaccine for COVID-19 began Wednesday, one day after the Russia Direct Investment Fund (RDIF) launched a new website to share the details of the vaccine with the public and scientists around the world.

article thumbnail

Argentina, Mexico line up to produce AstraZeneca, Oxford coronavirus vaccine

Bio Pharma Dive

The manufacturing deal could help supply Latin America with Oxford's shot, which is one of the most advanced in clinical testing.

article thumbnail

FDA accepts application for self-administered Xolair use

Pharma Times

If approved drug would offer a more flexible option for patients

Drugs 150
article thumbnail

UK’s second go at a contact tracing app heads for pilot study

pharmaphorum

After ditching its home-grown attempt at a coronavirus contact-tracing app for smartphones, the UK is ready to start pilot trials of a second version based on a platform developed by Apple and Google. The new NHS Test and Trace app is intended to be used as an add-on to the controversial national and local contact-tracing service, and was due to start initial trials yesterday on the Isle of Wight and among a group of NHS volunteers.

Trials 116
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

U.K. Government Secures 60 Million Doses of Novavax’s COVID-19 Vaccine Candidate

BioSpace

Novavax entered into an agreement to provide the United Kingdom with 60 million doses of the vaccine should it be approved, as well as a late-stage efficacy study in that country.

article thumbnail

Bristol Myers pledges to spend $300M on addressing racial, health disparities

Bio Pharma Dive

The drugmaker aims to double Black and Latinx representation in its executive ranks, among other commitments.

335
335
article thumbnail

How to Stay Food Safety Compliant and Be Inspection Ready, Even During a Pandemic

XTalks

While the COVID-19 pandemic has disrupted the way consumers shop and food manufacturers operate, food safety remains a top priority for all stakeholders. The entire food supply chain is committed to meeting this expectation despite the fact that our new normal is changing from day-to-day. Many companies have successfully transitioned their meetings, events and even happy hours to virtual platforms to meet social distancing recommendations.

article thumbnail

Emotional empathy is driving brand equity

pharmaphorum

How the COVID-19 pandemic is forging pharmaceutical brands into better shape. Day by day it becomes clearer that some brands are coming through the pandemic in better shape than ever. These are the brands that have clearly demonstrated emotional intelligence, that have shown emotional empathy to their target audience. They understand the current, heightened emotional state of their customers and respond to it in ways that show they give a damn.

Branding 112
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Celleron Therapeutics Gains Worldwide Rights to Shelved Roche Drug

BioSpace

Celleron Therapeutics signed a licensing agreement with Roche for the worldwide rights to cancer drug emactuzumab, a monoclonal antibody directed against colony-stimulating factor 1 (CSF-1R) expressed on macrophages.

Drugs 129
article thumbnail

A hedge fund bets on a biotech startup to bring new drugs to China

Bio Pharma Dive

The unusual startup already has partial rights to multiple drugs developed by MyoKardia and affiliates of BridgeBio, and plans to acquire many more.

Drugs 257
article thumbnail

What Happens When 3rd-Party Cookies Expire?

Pharma Marketing Network

2022 will usher in the demise of third-party cookies—that means pharma brands must change their approach to targeting and measurement. For decades, the third-party cookie has been a core component of any digital marketing strategy, allowing advertisers to deliver targeted ads and measure their effectiveness. However, with increased consumer privacy concerns and regulations, third-party cookies are set to expire by 2022.

article thumbnail

Verona Pharma to trial lung drug ensifentrine for COVID-19

pharmaphorum

Verona Pharma is to develop its lung drug ensifentrine for patients with COVID-19, joining the legions of drug companies repurposing their medicines to fight the pandemic. Based in the UK and US, Verona is due to start a phase 3 trial of ensifentrine in chronic obstructive pulmonary disease (COPD) later this year after encouraging results in phase 2.

Trials 111
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.